SCHEMBL24601325

SCHEMBL24601325

c1ccc2c(c1)c1ccccc1n2-c1ccc2c3c4c5ccc(-n6c7ccccc7c7ccccc76)cc5n5c6cc(-n7c8ccccc8c8ccccc87)ccc6c(c6c7ccc(-n8c9ccccc9c9ccccc98)cc7n(c2c1)c36)c45

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.48
ATM Q13315 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
GPR3 P46089 1/20 0.33
MAPT P10636 1/20 0.33
POLB P06746 2/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2C19 P33261 1/20 0.32
PTPN1 P18031 2/20 0.32
ALDH1A1 P00352 2/20 0.32
HDAC4 P56524 1/20 0.31
KMT2A Q03164 2/20 0.31
DUSP3 P51452 1/20 0.30
KIF11 P52732 1/20 0.30
MEN1 O00255 1/20 0.30
TSHR P16473 1/20 0.30
BRCA1 P38398 1/20 0.30
HSD17B10 Q99714 1/20 0.30
ALKBH5 Q6P6C2 1/20 0.30
FTO Q9C0B1 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22178604 0.98 KDM4E (0.47) KDM4EATML3MBTL1GPR3MAPT
SCHEMBL22178730 0.88 KDM4E (0.47) KDM4EATML3MBTL1GPR3MAPT
SCHEMBL24601408 0.87 KIF11 (0.38) KDM4EATML3MBTL1MAPTALDH1A1
SCHEMBL17995059 0.86 KDM4E (0.48) KDM4EATML3MBTL1GPR3MAPT
SCHEMBL24601326 0.86 KDM4E (0.48) KDM4EATML3MBTL1GPR3MAPT
SCHEMBL17146748 0.84 KDM4E (0.47) KDM4EATML3MBTL1GPR3MAPT
SCHEMBL24601623 0.84 ALKBH5 (0.45) KDM4EATML3MBTL1MAPTPOLB
SCHEMBL24601424 0.84 PGR (0.35) KDM4EATML3MBTL1KIF11
SCHEMBL26179742 0.83 KDM4E (0.46) KDM4EATML3MBTL1GPR3MAPT
SCHEMBL24425621 0.83 KDM4E (0.46) KDM4EATML3MBTL1GPR3POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220213113-A1 NITROGEN-CONTAINING CONDENSED CYCLIC COMPOUNDS, FLUORESCENCE EMITTERS, ORGANIC ELECTROLUMINESCENT DEVICES, AND MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES SAMSUNG ELECTRONICS CO., LTD. (KR) 2022-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220213113-A1 NITROGEN-CONTAINING CONDENSED CYCLIC COMPOUNDS, FLUORESCENCE EMITTERS, ORGANIC ELECTROLUMINESCENT DEVICES, AND MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES NCL, NOC2L, NOLC1 KDM4E 3163/4885ATM 953/4885L3MBTL1 2377/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.